Latest news
Loading news…
Organon develops and provides medicines and health solutions focused on women’s health, biosimilars, and established brands.
Organon was acquired by Sun Pharmaceutical in 2026 for $12B.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
4
Investments
1
Monthly Visits
Available in Pro Contacts
0
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 95
- Active products
- 23
- IT spend
- $135M
Investor Activity
- Investments
- 1
- Lead investments
- 1
- Portfolio orgs
- 1
Company Info
- Org types
- company, investor
- HQ
- Jersey City, New Jersey, United States
Signals & Scores
- Trend (7d)
- -0.1
- Trend (30d)
- -1
- Trend (90d)
- 5.1
Investments by Organon
Loading columns…
0 of 0Show
Page 1 / 1
Acquisitions by Organon
Loading columns…
0 of 0Show
Page 1 / 1
Key People at Organon
Managing Director, Asia Pacific
Executive Director & APJ Marketing and Commercial Lead
Head, Innovation Ecosystem Integration
VP, BT Corporate Functions and Global ERP
EVP & Chief Financial Officer
Executive Director, Engineering
Executive Clinical Account Specialist
Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Organon
Loading news…
FAQs about Organon
People who checked this page also checked these
Sectors Organon invests & acquires in
Browse the full Acquirezy directory.